Company Filing History:
Years Active: 1993-2014
Title: Shutsung Liao: Innovator in Cholesterol Management and Disease Treatment
Introduction
Shutsung Liao is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of medical science. He holds a total of 13 patents, focusing primarily on compounds that target various health disorders, including high cholesterol and related diseases. His innovative work has the potential to impact the treatment of conditions such as cancer, diabetes, and Alzheimer's disease.
Latest Patents
Among his latest patents, Liao has developed liver X receptor agonists, which are compounds designed to lower blood cholesterol levels. These compounds are defined by a specific formula, where R, A, D, X, Y, and Z are detailed in the specification. Additionally, he has disclosed methods for using these compounds to treat a range of disorders associated with high cholesterol concentrations. His work includes methods, kits, combinations, and compositions aimed at treating conditions where an activator of liver X alpha is indicated.
Career Highlights
Shutsung Liao has had a distinguished career, working with notable organizations such as Arch Development Corporation and the University of Chicago. His experience in these institutions has allowed him to advance his research and develop innovative solutions to pressing health issues.
Collaborations
Liao has collaborated with esteemed colleagues, including Richard Hiipakka and Ching Song. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
Shutsung Liao's work exemplifies the intersection of innovation and healthcare, particularly in the management of cholesterol-related disorders. His patents and research continue to pave the way for advancements in medical treatments, showcasing the importance of innovation in improving health outcomes.